glycine glp 1 GLP-1/GIP+B12 boosting benefits GLP-1 Microdose Protocol with Glycine

All of three dual agonist peptides, tirzepatide, MAR709 and CY-5, have a C-terminal same as exenatide but no convincing reasons have been put forward and its use is more likely an inertia from MAR709

They are powerful, effective tools

Extending your current lower dose for an extra two to four weeks can give your digestive system more time to adapt

If you are starting or already taking a GLP-1 agent, this is not cause for alarm

By offering access to GLP-1 medications through telehealth, FuturHealth helps interrupt this cycle

A GLP-1 RA or tirzepatide may be considered as an add-on (to metformin plus an SGLT2 inhibitor) for glycaemic control, if initial therapy is insufficient